Eletriptan hydrobromide 20 mg/1
Eletriptan hydrobromide · TABLET, FILM COATED · Zydus Lifesciences Limited
Eletriptan Hydrobromide is a prescription tablet used to treat migraine headaches with or without aura. It works by narrowing blood vessels around the brain and reducing substances in the body that can trigger headaches, nausea, sensitivity to light and sound, and other migraine symptoms.
Key Facts
- Brand Name
- Eletriptan hydrobromide
- Generic Name
- Eletriptan hydrobromide
- NDC Code (Product)
70771-1107- Manufacturer
- Zydus Lifesciences Limited
- Strength
- 20 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- ANDA206409
- Marketing Start
- 07/12/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is Eletriptan hydrobromide used for?
Eletriptan Hydrobromide is a prescription tablet used to treat migraine headaches with or without aura. It works by narrowing blood vessels around the brain and reducing substances in the body that can trigger headaches, nausea, sensitivity to light and sound, and other migraine symptoms.
Is Eletriptan hydrobromide a controlled substance?
Eletriptan hydrobromide is not classified as a controlled substance by the DEA.
What is the generic name for Eletriptan hydrobromide?
The generic name for Eletriptan hydrobromide is Eletriptan hydrobromide. There are 9 other brand versions of Eletriptan hydrobromide.
What is the NDC code for Eletriptan hydrobromide 20 mg/1?
The NDC (National Drug Code) for Eletriptan hydrobromide 20 mg/1 is 70771-1107, listed by Zydus Lifesciences Limited.
Other Eletriptan hydrobromide Dosages
Other Eletriptan Brands
See all →- Eletriptan Hydrobromide40 mg/159651-105
- Eletriptan Hydrobromide20 mg/159651-104
- Eletriptan Hydrobromide40 mg/180425-0408
- Relpax40 mg/158151-368
- Eletriptan Hydrobromide40 mg/10378-4288
- Eletriptan Hydrobromide20 mg/124689-167
- Relpax20 mg/158151-367
- Eletriptan Hydrobromide20 mg/10378-4287
- Eletriptan Hydrobromide20 mg/10093-8310
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)